Maryland, United States – The newest announcement from the US Food and Drug Administration gives a go signal for the use of the Beleodaq treatment. This can specifically treat non-Hodgkin lymphoma.
This has already been an approved drug since 2009. However, its use is not that wide since there were no verifications coming from the government.
The approval coming from the FDA made sure that there are more options for patients. Since this is a very rare disease, they need all the help that they can get. It will not be enough if urgent care clinics have the best experts. They will also need the medication that will help them get over the whole illness.
The Beleodaq Treatment and Its Efficiency on the Patients
A lot of tests have been done before the Beleodaq treatment is granted the go signal to sell. First, they have worked with 129 participants to notice the changes that it will give. Luckily, the cancer of the patients went down by 25.8 percent. The treatment made a significant change in its size.
On the one hand, there are different side effects to the treatment. They will need contacts of urgent care near me because nausea and vomiting happen more often. Lower red blood cells count was also seen on the patients that were treated. Other side effects also include fever and the fatigue.
Different Drugs That Were Also Given the Same Recognition
The Beleodaq treatment is not the only remaining option for those with t-cell lymphoma. There are two other drugs that have been widely available since five years ago. The first was the Fotolyn. This was approved in 2009.
The second was approved in 2011. This is the Istodax. However, this drug is not applicable for those who do not have prior experiences with such treatment. The doctors say that there should be a lot of preliminary tests to be done before they are to use them.
The next step for the government is how to make these abundant in any urgent care clinic. There should be proper distribution in different parts of the United States.
The Beleodaq treatment could still improve. With the number of its side effects, urgent care should still be at stand by for the patient. How do you think will scientists take off from this announcement? How long will it take to create a better drug for t-cell lymphoma?
